Omegga develops invasive in-ovo-sexing technology to prevent the killing of 7 billion male laying hens.
Omegga GmbH has raised $11.7M in total funding. The most recent round was Seed. The last funding was announced in April 2026.
Omegga GmbH's investors include IQ Capital, Capnamic, EIC Accelerator, GETTY.
Omegga GmbH is headquartered in Munich, Germany.
Omegga develops invasive in-ovo-sexing technology to prevent the killing of 7 billion male laying hens.
Omegga GmbH is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Omegga GmbH — Funding & Investors." VCBacked, April 24, 2026, https://www.vcbacked.co/company/omegga-gmbh. Accessed August 14, 2026.
VCBacked. (2026). Omegga GmbH — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/omegga-gmbh
{{cite web |title=Omegga GmbH — Funding & Investors |url=https://www.vcbacked.co/company/omegga-gmbh |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated